Notes to the unaudited interim condensed consolidated statement of (income) loss - Investment in Hepalys is accounted for using the equity method (Details) - EUR (€) € in Thousands |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Feb. 24, 2026 |
Jan. 14, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Investments accounted for using the equity method | |||||
| Non-current assets | € 5,244 | € 5,042 | |||
| Current assets | 245,966 | 244,469 | |||
| Total assets | 251,210 | 249,511 | |||
| Shareholders' equity | 59,002 | € (8,909) | (28,522) | ||
| Current liabilities | 64,588 | 77,378 | |||
| Equity and liabilities | 251,210 | 249,511 | |||
| Balance at the beginning | (28,522) | (106,647) | (106,647) | ||
| Net loss for the period | (69,467) | (175,882) | |||
| Other comprehensive income | (102) | (167) | |||
| Balance at the end | 59,002 | € (8,909) | (28,522) | ||
| Carrying amount | € 528 | € 527 | |||
| Hepalys Pharma, Inc | |||||
| Investments accounted for using the equity method | |||||
| Group's share in % | 13.68% | 13.92% | 13.68% | 15.00% | 14.64% |
| Group's share | € 1,832 | € 1,869 | |||
| Elimination of unrealized profit on downstream sales | (1,340) | (1,378) | |||
| Goodwill | 37 | 37 | |||
| Carrying amount | 528 | 527 | |||
| Hepalys Pharma, Inc | |||||
| Investments accounted for using the equity method | |||||
| Non-current assets | 11,556 | 12,729 | |||
| Current assets | 1,966 | 183 | |||
| Total assets | 13,522 | 12,912 | |||
| Shareholders' equity | 13,389 | 12,766 | |||
| Current liabilities | 133 | 146 | |||
| Equity and liabilities | 13,522 | 12,912 | |||
| Balance at the beginning | 12,766 | € 18,368 | 18,368 | ||
| Net loss for the period | (1,642) | € (2,158) | (3,816) | ||
| Other comprehensive income | (70) | (1,786) | |||
| Capital variations | 2,335 | ||||
| Balance at the end | € 13,389 | € 12,766 | |||
| X | ||||||||||
- Definition The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of assets that do not meet the definition of current assets. [Refer: Current assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Entity's share of net assets in investments accounted for using the equity method No definition available.
|
| X | ||||||||||
- Definition Increase (decrease) through capital variations, equity No definition available.
|
| X | ||||||||||
- Definition Amount of intercompany eliminations in associates No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|